| Name | Title | Contact Details |
|---|
E-hazard Management is a Louisville, KY-based company in the Business Services sector.
City Of Cimarron is a Cimarron, KS-based company in the Business Services sector.
The Premier Group of Companies falls under the Corporate umbrella of their sponsors - The Group. The Group has been in commerce and industry since 1950 and has maintained its place amongst the largest producers of white crystalline sugar ever since. The Groups scope of operations is wide and diversified, from sugarcane crushing and beet slicing, to ethanol distilleries and state of the art flour mills. Alongside these primary industry ventures, The Group is successfully engaged in the operation of diplomatic bonded warehouse facilities in Karachi and bulk handling facilities at the Karachi terminal, the production of high grade polypropylene products with worldwide exports, the distribution of consumer products and information technology, in real-estate holdings and even in the representation of multinational companies in Pakistan. The Group is also actively invested in introducing reforms in the agriculture sector, ranging from the introduction of state of the art Silo storage facilities in collaboration with provincial governments for the efficient storage of wheat grain, to promoting ecological practices in the agriculture sector, specifically in the field of variety sugar cane cultivation. The Group continues to diversify, evolve and expand its realm of operations, with nationwide industrial and trading ventures in each province backed by a network of supporting offices in the business areas of Mardan, Lahore, Rawalpindi, Islamabad, and Karachi. The head office of the Group is situated at 20-A, Kings Arcade, F-7 Markaz, Islamabad.
LaMagna and Associates is a Gaithersburg, MD-based company in the Business Services sector.
What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. Were a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. We are a vibrant company full of hope, possibilities, and a belief that, working together as One Editas, we can truly revolutionize the development of medicines. We are on an important journey to unlock the full potential of genome editing technology. A journey fueled by our distinct culture, expert team of Editas Medicine ‘Editors, and the patients we aspire to help around the world. Connect with us to hear about the tremendous progress and scientific advancements weve already made and the next breakthrough on the horizon. If you are ingenious, passionate and resilient, come join the revolution. Repairing broken genes is only the beginning.